The American Association for Cancer Research (AACR) released its annual cancer progress report Wednesday, Sept. 12, revealing increasing cases despite progress made in diagnosing and treating various cancers.

Contrast-enhanced ultrasound may be more accurate than CT or MRI in identifying cancerous tumors in the kidneys and could reduce unnecessary biopsies and surgical procedures by half, according to research presented at the 2018 International Contrast Ultrasound Society’s Bubble Conference in Chicago.

New research published in Scientific Reports details the accuracy of optical microscope technology in identifying malignant brain tumors.

Researchers found that incorporating lung nodule features and patient-specific characteristics improved the positive predictive ability of a cancer screening model while maintaining low-dose CT scan sensitivity, according to research published in the Journal of the American College of Radiology.

German and Russian researchers have developed a new injection diagnosis system based on magnetoferritin that may improve MRI accuracy, cancer diagnosis and treatment options.

The U.S. Preventative Services Task Force (USPSTF) issued updated cervical cancer screening guidelines Aug. 21 that stated a human papillomavirus (HPV) test alone is as effective as the commonly used Pap smear.

Veterans who utilize Medicare and other fee-for-service health systems for prostate cancer care are more likely to receive guideline-discordant imaging than those treated at the Veterans Health Administration (VA), according to a study published Aug. 17 in JAMA Network Open.

“Treatment effect is more reliably determined on imaging at 90 days following SIRT, however imaging at one-month post-SIRT is still frequently performed,” Shamar Young, MD, and colleagues wrote. “This raises the question as to whether or not imaging at one month following SIRT is clinically warranted.”